Summer Comfort
New air conditioners for individuals with MS
Get relief from summer heat thanks to our generous donors. For the 29th year the Multiple Sclerosis Society of Portland, Oregon (MSSP) is offering free window air conditioners to those living with Multiple Sclerosis in Oregon and SW Washington. Email MSSP at info@msoregon.org
As a non-profit agency we strive to serve as many clients as possible. For this reason we are unable to accommodate special needs i.e. free-standing or vertical units. The machines we offer work best in windows that open (up and down) versus sliding (left to right). Some folks with sliding windows have accepted the units and inserted a piece of plexy glass or other material to close the space above the air conditioner. Once all your paperwork is received you are then placed on a waiting list. When you are approved the unit is sent via UPS or other professional delivery service. You become the owner and are responsible for the installation, maintenance and for submitting all warranty information.
Application Instructions
In order to apply, you will need to provide documentation of your MS diagnosis. This can be either a medical chart note that includes your name and diagnosis, SSI/SSDI verification or the cardboard cover off of one of the following medications:
Injectable medications
Avonex® (interferon beta-1a)
Betaseron® (interferon beta-1b)
Copaxone® (glatiramer acetate)
Extavia® (interferon beta-1b)
Glatopa® (glatiramer acetate—generic of Copaxone)
Plegridy® (peginterferon beta-1a)
Glatopa (glatiramer acetate – generic equivalent of Copaxone 20mg and 40mg doses)
Rebif® (interferon beta-1a)
Kesimpta® (ofatumumab)
Oral medications
Aubagio® (teriflunomide)
Bafiertam™ (monomethyl fumarate)
Dimethyl Fumarate (dimethyl fumarate – generic equivalent of Tecfidera)
Gilenya® (fingolimod)
Mavenclad® (cladribine)
Mayzent® (siponimod)
Tecfidera® (dimethyl fumarate)
Vumerity® (diroximel fumarate)
Zeposia® (ozanimod)
Infused medications
Lemtrada® (alemtuzumab)
Novantrone® (mitoxantrone)
Ocrevus® (ocrelizumab)
Tysabri® (natalizumab)